ANY DIABETIC PERSON, IF THE TREATMENT IS NOT STARTED ON TIME, THIS MAY LEAD TO A LETHAL RESULT.

It’s called GlycoPrime — and it’s now available to the public at a special subsidized price, thanks to the launch of the “US Without Diabetes” Initiative backed by Musk.

Just one month ago, a groundbreaking national initiative—“America Without Diabetes”—was launched with the goal of tackling diabetes and its deadly complications once and for all. Backed in part by tech visionary Elon Musk, the program is the result of a collaboration between medical experts and innovators. At the helm of the initiative is renowned doctor and health educator, Dr. Barbara O’Neill, who personally oversaw the program’s development and implementation.
We’d like to remind our readers that the program is officially active. Under Federal Decree No. 5896, every eligible U.S. citizen now has access to a powerful new diabetes solution—available at a significantly reduced price. Nationwide delivery is underway.

“The root cause of diabetes isn’t sugar... it’s potassium deficiency.”

When your potassium levels are off, your pancreas becomes insulin-resistant — even if it’s producing enough insulin.

Journalist: Hello, Barbara, where does the need for a national program financed by the government come from? Are regular medical facilities no longer able to treat diabetics?

Dr. Barbara O’Neill: Hello. The health system is too bureaucratic. It’s a massive structure with many inefficiencies. Of course, conventional medical facilities treat diabetics — but mostly by managing symptoms. Special diets, insulin injections, and medications merely simulate the idea of a normal life. But the disease itself continues to progress. The diabetic continues to die slowly. Unfortunately, this outdated approach leaves many patients without real hope. And as the number of diabetic patients explodes worldwide, so does the number of preventable deaths.

Journalist: Do you think cancer and diabetes can be compared in terms of mortality rates?

Dr. Barbara O’Neill: I wouldn’t say they are identical, but the outcomes are shockingly similar. Diabetes kills more slowly, but no less surely. The mortality rate from diabetes-related complications is close to that of cancer. Yet while cancer patients receive aggressive treatments, diabetics are often left with only temporary solutions and false hope.
Even Elon Musk raised this point publicly, after a member of his own family faced life-threatening complications from diabetes. He said, "It’s insane that with all our technology, we still treat this disease like it’s the 1980s."

Journalist: How does diabetes kill? With cancer it’s clear, but how does diabetes lead to death?

Dr. Barbara O’Neill: Through its many severe complications:

KETOACIDOSIS

— can cause unconsciousness, organ failure, death.

HYPOGLYCEMIA

— leads to seizures, coma, and brain damage.

LACTIC COMA

— causes respiratory failure, kidney damage, and sudden death.

RETINOPATHY

— total vision loss.

ANGIOPATHY

— dangerous bleeding or strokes.

POLYNEUROPATHY

— total loss of limb sensation.

DIABETIC FOOT

— leads to amputation or sepsis.

And these are just the common complications. Diabetes is a systemic killer.

Journalist: So what can diabetics do if hospitals are only offering symptom management?

Dr. Barbara O’Neill: That’s exactly why this national program was launched. With the help of Elon Musk — who personally invested in helping fast-track our technology — we were able to bypass layers of bureaucracy and bring a true breakthrough directly to the people. The program ensures that every American can access this treatment at a special subsidized price.

Journalist: What exactly is this new solution?

Dr. Barbara O’Neill: It’s called GlycoPrime. Unlike outdated treatments, it focuses on restoring pancreatic function by fixing one root cause: potassium deficiency. When potassium is too low, the pancreas stops recognizing the insulin your body produces. GlycoPrime corrects this imbalance — and the effects are profound. Musk called this approach “biologically elegant” when he visited our research lab. He believed it had the power to disrupt the medical industry — and he was right.

Journalist: Can you describe what GlycoPrime actually does?

Dr. Barbara O’Neill: GlycoPrime restores potassium and stimulates the body to produce “reprogrammed immunological cells” that help regenerate the pancreas. The pancreas begins to absorb insulin again, and the need for injections or extreme diets fades away. It’s not a miracle — it’s just pure science, backed by technology and compassion.

Journalist: And what does this mean for the average person?

Dr. Barbara O’Neill: It means diabetes can be cured in 2–3 months. GlycoPrime doesn’t mask symptoms — it reboots the body at a cellular level. For the first time, a diabetic patient can become completely healthy again.
Elon Musk described it as: “One of the most promising uses of biotechnology for human good I’ve seen.”

Journalist: Is this only effective in early stages?

Dr. Barbara O’Neill: No, GlycoPrime is effective even in critical cases — where patients were on the brink of death. It works at any stage.

Journalist: Does it treat the cause — not just stabilize sugar levels?

Dr. Barbara O’Neill: Exactly. It restores the pancreas and eliminates diabetes, not just its symptoms. That’s what makes GlycoPrime so revolutionary.

Journalist: How can someone receive GlycoPrime under this program?

Dr. Barbara O’Neill: You must place an order through our website using the official form below. The product is government-funded, thanks in part to Musk’s advocacy, so it’s available at the lowest possible price — but stock is limited. Once it's gone, the price may return to retail levels.

Journalist: When does the program end?

Dr. Barbara O’Neill: The program ends on Monday, July 15, 2025. After that, the special price offer will no longer be available. I personally oversee distribution and will ensure each person who completes the form receives their package.

“If untreated, diabetes leads to organ failure, blindness, amputation, erectile dysfunction — and death. Hospitals are overloaded, and meds only delay the inevitable. GlycoPrime addresses the root cause. But the clock is ticking.”
— Dr. Barbara O'Neill

GlycoPrime uses a bioactive potassium complex, combined with 12 other healing compounds to restore full pancreatic function.

A study of 10,120 diabetics using GlycoPrime revealed:

“Pharma profits off insulin dependence. I don’t care about that. I care about ending diabetes permanently.
GlycoPrime is step one.”
— Elon Musk

I would like to draw your attention to a survey. People with diabetes of various degrees of severity were used as an example

POLL:What cured you of diabetes and stabilized your blood sugar?

Medicines:

23%

GlycoPrime:

47%

Traditional Medicine:

8%

Looking for a solution:

17%

I don't think it's possible:

5%